Bill > HR2085

This bill, known as the Mental Health Research Accelerator Act of 2025, establishes a tax credit to incentivize translational research on neurodegenerative diseases and psychiatric conditions. The bill provides a 25 percent tax credit for expenses related to such research, with an annual national credit limitation that starts at $1 billion in 2026, increases to $2 billion from 2027-2030, and then returns to $1 billion in 2031. The credit allocation will be managed by the Secretary of the Treasury in consultation with health agencies, with criteria including scientific merit, comprehensive research phases, emphasis on new therapeutics and devices for neurological and psychiatric disorders, and standards for drug repurposing and public-private partnerships. Tax-exempt entities like government agencies or non-profit organizations can transfer their credit to eligible project partners, allowing for more flexible research funding. The bill also ensures that these research expenses cannot be double-counted for other research tax credits and sets an expiration date of December 31, 2035, for claiming the credit. The overall goal is to encourage and financially support critical research into mental health and neurodegenerative conditions by providing a meaningful tax incentive to researchers and institutions.

Budget and Finance

https://www.congress.gov/bill/119th-congress/house-bill/2085/all-info